Peter Loftus
Wall Street Journal reporter who produced the episode's reporting on Kenvue and the Tylenol controversy; provides on-the-record explanations and context for the story.
Top 3 podcasts with Peter Loftus
Ranked by the Snipd community
202 snips
May 21, 2025 • 19min
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?
In this insightful discussion, Peter Loftus, a reporter with the Wall Street Journal, unpacks the surprising ousting of Novo Nordisk's CEO, Lars Jorgensen, amid Ozempic's skyrocketing success. He explores the unique nonprofit structure of Novo Nordisk and how it affects corporate governance. The conversation also delves into the fierce rivalry with Eli Lilly, revealing how the market landscape for anti-obesity drugs has evolved, and the implications of recent clinical trial setbacks on investor confidence.
132 snips
Sep 30, 2025 • 22min
Inside the Crisis at Tylenol
In this discussion, Wall Street Journal reporter Peter Loftus provides insight into the crisis surrounding Tylenol, sparked by Donald Trump's controversial claims linking acetaminophen to autism. Loftus elaborates on Kenvue CEO Kirk Perry's swift response to the uproar and the pressure he faced. They delve into the nuances of the research on acetaminophen and autism, contrasting it with past PR crises, and explore the wider implications for pharma companies under a politicized administration. This riveting conversation offers a deep dive into crisis management in the modern age.
41 snips
Apr 10, 2026 • 13min
Biotech in China is Booming. Big Pharma is Paying Attention.
Peter Loftus, WSJ biotech reporter, explains China’s fast climb from generics to cutting-edge biologics and why big pharma is scouting Chinese startups. Kate Clark, WSJ tech reporter, profiles college dropouts forming AI founder houses and the VCs paying their bills. Short takes cover investor urgency, bubble risks, biotech strengths, and how global pipelines are shifting.
